AnaptysBio (ANAB) IPO Opens Up 7%

Today's IPO for AnaptysBio, Inc. (NASDAQ: ANAB) opened for trading at $16 after pricing its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15 per share.

Credit Suisse and Stifel are acting as joint book-running managers for the offering. JMP Securities and Wedbush PacGrow are acting as co-managers.

AnaptysBio is a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

You May Also Be Interested In

• Rectitude Holdings (RECT) Announces 2M Share IPO at $4-$6/sh
• Rubrik IPO: 5 key things to know
• Nordson Corp. (NDSN) Appoints Daniel Hopgood as CFO